(Press-News.org) Screening men with a family history of prostate cancer for a range of gene mutations can identify those who are at high risk of aggressive forms of the disease and in need of lifelong monitoring, a new study has shown.
Scientists at The Institute of Cancer Research, London, found screening of men who had multiple relatives with prostate cancer was able to pick up 14 mutations in known cancer genes that predicted the development of the disease.
The research was mainly funded by Prostate Cancer UK with additional support from Cancer Research UK, and is published in the British Journal of Cancer today (Friday).
The findings are important because they demonstrate not only that some men have a genetic profile that puts them at higher risk of prostate cancer, but that particular genetic profiles match to a higher risk of advanced, invasive disease. A big challenge facing prostate cancer researchers is to find ways of predicting which men will have life-threatening forms of the disease, to allow treatment to be tailored more effectively.
Scientists at The Institute of Cancer Research (ICR) analysed blood samples from 191 men with prostate cancer at several different UK centres. They were able to use new 'second generation' DNA sequencing technologies to assess mutations in 22 different known cancer genes at once – opening up for the first time the prospect of rapid genetic screening for prostate cancer for a wide range of mutations.
The researchers looked at men with a history of three or more cases of prostate cancer in their close family, in order to mirror use of family history as a criterion for existing gene testing programmes in breast cancer.
The researchers found 13 'loss of function' mutations – which prevent the genes from producing a properly working protein – in eight DNA repair genes. The genes tested for were BRCA1 and BRCA2, which are already routinely tested for in women with a strong family history of breast or ovarian cancer, plus ATM, CHEK2, BRIP1, MUTYH, PALB2 and PMS2.
Men with any of these 13 mutations were much more likely than those without to develop an advanced, invasive form of cancer which spread to the lymph nodes or other parts of the body, and to die from the disease.
Study co-leader Professor Ros Eeles, Professor of Oncogenics at The Institute of Cancer Research, London, and Honorary Consultant at The Royal Marsden NHS Foundation Trust, said:
"Our study shows the potential benefit of putting prostate cancer on a par with cancers such as breast cancer when it comes to genetic testing. Although ours was a small, first-stage study, we proved that testing for known cancer mutations can pick out men who are destined to have a more aggressive form of prostate cancer.
"We already have the technical capabilities to assess men for multiple mutations at once, so all that remains is for us to do further work to prove that picking up dangerous mutations early can save lives. If so then in the future, genetic testing may be needed as part of the prostate cancer care pathway."
Fellow study co-leader Dr Zsofia Kote-Jarai, Senior Staff Scientist at The Institute of Cancer Research, London, said:
"One of the important messages to come out of our study is that mutations to at least eight genes – and probably many more – greatly increase the risk of aggressive prostate cancer. Any future screening programme would need to assess as many of these genes as possible – more than we currently look for in women at risk of breast cancer, for example."
Dr Iain Frame, Director of Research at Prostate Cancer UK, said:
"The minefield of prostate cancer diagnosis is one of the biggest hurdles facing treatment of the disease today. Current tests fail to differentiate between aggressive cancers that could go on to kill, and cancers that may never cause any harm. This lack of clarity means that too often men and their doctors are left having to make incredibly difficult decisions on whether to treat the disease or not.
"We urgently need to understand more about which men are at risk of developing prostate cancer and in particular aggressive forms of the disease. Genetic testing to predict risk could revolutionise how we treat the 40,000 men diagnosed with the disease every year in the UK. These results are exciting as they add to the growing weight of evidence that men with a family history of prostate cancer who possess certain genes may be at higher risk, providing us with another crucial piece of the jigsaw."
INFORMATION:
Notes to Editors
For more information contact the ICR press office on 020 7153 5312 / henry.french@icr.ac.uk. For enquiries out of hours, please call 07976 751984.
The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes.
Scientists and clinicians at The Institute of Cancer Research (ICR) are working every day to make a real impact on cancer patients' lives. Through its unique partnership with The Royal Marsden Hospital and 'bench-to-bedside' approach, the ICR is able to create and deliver results in a way that other institutions cannot. Together the two organisations are rated in the top four cancer centres globally.
The ICR has an outstanding record of achievement dating back more than 100 years. It provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today it leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.
As a college of the University of London, the ICR provides postgraduate higher education of international distinction. It has charitable status and relies on support from partner organisations, charities and the general public.
The ICR's mission is to make the discoveries that defeat cancer. For more information visit http://www.icr.ac.uk
About Prostate Cancer UK
Prostate Cancer UK fights to help more men survive prostate cancer and enjoy a better quality of life. We support men and provide vital information. We find answers by funding research into causes and treatments. And we lead change, raising the profile of the disease and improving care. We believe that men deserve better.
Prostate cancer is the most common cancer diagnosed in men in the UK. Over 40,000 men are diagnosed with prostate cancer every year. Every hour 1 man dies from prostate cancer. One in four Black men will develop prostate cancer at some point in their lives.
Anyone with concerns about prostate cancer can call Prostate Cancer UK's confidential Helpline on 0800 074 8383 or visit http://www.prostatecanceruk.org. The helpline is free to landlines, staffed by specialist nurses, and open from 9am to 6pm Monday to Friday with late opening until 8pm on Wednesdays.
About Cancer Research UK
Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research
The charity's pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives.
Cancer Research UK receives no government funding for its life-saving research. Every step it makes towards beating cancer relies on every pound donated.
Cancer Research UK has been at the heart of the progress that has already seen survival rates in the UK double in the last forty years.
Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
Together with its partners and supporters, Cancer Research UK's vision is to bring forward the day when all cancers are cured.
For further information about Cancer Research UK's work or to find out how to support the charity, please call 0300 123 1022 or visit http://www.cancerresearchuk.org. Follow us on Twitter and Facebook.
About the British Journal of Cancer (BJC)
The BJC is owned by Cancer Research UK. Its mission is to encourage communication of the very best cancer research from laboratories and clinics in all countries. Broad coverage, its editorial independence and consistent high standards have made BJC one of the world's premier general cancer journals. http://www.bjcancer.com
Genetic screening can identify men with advanced prostate cancer
2014-02-21
ELSE PRESS RELEASES FROM THIS DATE:
Greece's deepening health crisis
2014-02-21
Greece's health crisis is worsening as a result of continued healthcare budget cuts, says a new study published in the medical journal, The Lancet. Researchers say the harmful effects of austerity are linked to the increasing inability of patients to access the health system, large rises in the incidence of infectious disease, and a deterioration in the overall mental health of Greek people.
The authors from the University of Oxford, the University of Cambridge and the London School of Hygiene and Tropical Medicine find that Greece has had the largest cutbacks to the ...
Legal harvest of marine turtles tops 42,000 each year
2014-02-21
A new study has found that 42 countries or territories around the world permit the harvest of marine turtles – and estimates that more than 42,000 turtles are caught each year by these fisheries.
The research, carried out by Blue Ventures Conservation and staff at the University of Exeter's Centre for Ecology and Conservation, is the first to comprehensively review the number of turtles currently taken within the law and assess how this compares to other global threats to the creatures.
All seven marine turtle species are currently listed on the IUCN Red List of Threatened ...
Skin tumor vaccine shows promise in wild mice, rising hope for transplant patients
2014-02-21
Papillomaviruses (linked to cervical cancer when they infect the mucosal tissue in the female reproductive tract) can also infect normal skin, where they cause warts and possibly non-melanoma skin cancer, mostly in immune-suppressed organ transplant patients. An article published on February 20th in PLOS Pathogens suggests that vaccination might prevent virus-associated benign and malignant skin tumors.
Transplant recipients need to take immunosuppressive drugs for the rest of their lives to prevent rejection of the transplanted organ. Among the side effects of these ...
Many kidney disease patients experience hazardous events related to their medical care
2014-02-21
Washington, DC (February 20, 2014) — In addition to experiencing negative health effects from their disease, patients with chronic kidney disease (CKD) are also at risk of experiencing hazardous events potentially related to medical treatments they receive. A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) finds that low blood sugar and high blood potassium being common complications of their medical care.
Patients with CKD are susceptible to experiencing harm related to the care they receive due to their impaired kidney ...
Biopsies before transplantation do not determine success of donated kidneys
2014-02-21
Highlights from two studies
Biopsy-detected injury in donated kidneys was modestly associated with a delay in organ function in the first week after transplantation, but only for donor kidneys already known to be at high risk. Donor kidney biopsies frequently underreported kidney injury with substantial variability.
There was a large degree of overlap between the results of biopsies from kidneys that were deemed unsuitable for transplantation and kidneys that were approved for transplantation. The quality of biopsies used in acceptance decisions was low.
Nearly 100,000 ...
Younger people, men and those without children more likely to drop out of HIV care in South Africa
2014-02-21
Analysis carried out by an academic at Royal Holloway, University of London has revealed that younger people, men and those without children are more likely to stop attending clinics for HIV treatment in South Africa.
Dr Michael Evangeli, from the Department of Psychology at Royal Holloway, worked alongside colleagues at the University of Southampton and the University of KwaZulu Natal, South Africa. The academics used data collected in a study, which is published in the journal PLOS ONE, that followed the progress of 380 HIV positive people eligible for HIV treatment ...
CNIO team explains lower cancer incidence rate in patients with central nervous system disesase
2014-02-21
Epidemiological studies demonstrate that diseases of the central nervous system such as Alzheimer, Parkinson and schizophrenia protect against cancer. The most remarkable example is Alzheimer's disease, which can reduce the risk of suffering from cancer by up to 50%. Various theories have been put forward in an attempt to explain this relationship between diseases at a first glance seem to be so different from the pharmacological, genetic and environmental perspectives. However, the available results were not consistent enough to confirm these models.
Alfonso Valencia, ...
NASA researcher finds planet-sized space weather explosions at Venus
2014-02-21
Researchers recently discovered that a common space weather phenomenon on the outskirts of Earth's magnetic bubble, the magnetosphere, has much larger repercussions for Venus. The giant explosions, called hot flow anomalies, can be so large at Venus that they're bigger than the entire planet and they can happen multiple times a day.
"Not only are they gigantic," said Glyn Collinson, a space scientist at NASA's Goddard Space Flight Center in Greenbelt, Md. "But as Venus doesn't have a magnetic field to protect itself, the hot flow anomalies happen right on top of the planet. ...
New apps may help detect seizures, treat strokes
2014-02-20
PHILADELPHIA – Two new smart phone applications may help people detect epileptic seizures and get better stroke treatment, according to two studies released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014.
In the first study, an epilepsy app was designed to help non-doctors determine if a person is having an epileptic seizure.
"It can often be difficult to determine whether someone is having an epileptic seizure," said study author Victor Patterson, MD, a neurologist from Belfast, UK. ...
Western University primatologist teams with international group to save lemurs
2014-02-20
Lemurs, the most endangered mammal group on Earth, represent more than 20 per cent of the world's primates. Native only to Madagascar, more than 90 percent of the species are threatened with extinction.
A Western University primatologist has teamed with 18 lemur conservationists and researchers, many of whom are from Madagascar or have been working there for decades, to devise an action plan to save Madagascar's 101 lemur species. The action plan contains strategies for 30 different priority sites for lemur conservation and aims to help raise funds for individual projects. ...